Discover
XERS
Xeris Biopharma Holdings, Inc.
8.00
2 x 5.85
2 x 10.24
bid
ask
+
0.08
1.01%
2 @ 07:42 AM
8.11 +0.11 (1.38%)
| Ytd | 1.91% | |
| 1y | 71.67% |
7.91
day range
8.20
4.52
52 week range
10.08
| Open | 7.95 | Prev Close | 7.92 | Low | 7.91 | High | 8.20 | Mkt Cap | 1.38B |
| Vol | 2.72M | Avg Vol | 1.74M | EPS | 0.07 | P/E | 114.29 | Forward P/E | 20.05 |
| Beta | 0.90 | Short Ratio | 8.22 | Inst. Own | 62.38% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 6.50 | 200-d Avg | 7.03 | 1yr Est | 11.29 |
| Income Statement | |||
| Total Revenue | 83.13M | ||
| Revenues (USD) | 83.13M | ||
| Cost of Revenue | 10.57M | ||
| Gross Profit | 72.55M | ||
| Operating Expenses | 64.64M | ||
| Research and Development Expense | 8.78M | ||
| Selling, General and Administrative Expense | 53.14M | ||
| Operating Income | 7.92M | ||
| Interest Expense | 6.88M | ||
| Net Income | 2.23M | ||
| Net Income Common Stock | 2.23M | ||
| Net Income Common Stock (USD) | 2.23M | ||
| Consolidated Income | 2.23M | ||
| Earnings per Basic Share | 0.01 | ||
| Earnings per Basic Share (USD) | 0.01 | ||
| Earnings per Diluted Share | 0.01 | ||
| Earning Before Interest & Taxes (EBIT) | 9.12M | ||
| Earning Before Interest & Taxes (USD) | 9.12M | ||
| Weighted Average Shares | 170.52M | ||
| Weighted Average Shares Diluted | 177.63M | ||
| Balance Sheet | |||
| Cash and Equivalents | 111.75M | ||
| Cash and Equivalents (USD) | 111.75M | ||
| Trade and Non-Trade Receivables | 56.30M | ||
| Current Assets | 251.68M | ||
| Property, Plant & Equipment Net | 26.98M | ||
| Total Assets | 392.01M | ||
| Debt Current | 6.27M | ||
| Total Debt | 258.55M | ||
| Current Liabilities | 118.59M | ||
| Debt Non-Current | 252.28M | ||
| Total Liabilities | 379.00M | ||
| Accumulated Retained Earnings (Deficit) | -669.07M | ||
| Accumulated Other Comprehensive Income | -24.00K | ||
| Shareholders Equity | 13.01M | ||
| Shareholders Equity (USD) | 13.01M | ||
| Assets Non-Current | 140.33M | ||
| Total Debt (USD) | 258.55M | ||
| Goodwill and Intangible Assets | 108.23M | ||
| Inventory | 74.23M | ||
| Liabilities Non-Current | 260.41M | ||
| Trade and Non-Trade Payables | 11.47M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.21M | ||
| Net Cash Flow from Financing | -8.84M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 708.00K | ||
| Capital Expenditure | -325.00K | ||
| Issuance (Purchase) of Equity Shares | -8.84M | ||
| Net Cash Flow from Investing | -325.00K | ||
| Net Cash Flow from Operations | 9.87M | ||
| Share Based Compensation | 4.14M | ||